A programmable dual-RNA-guided DNA endonuclease in adaptive 479 bacterial immunity, Science, vol.337, pp.816-821, 2012. ,
Multiplex genome engineering using CRISPR/Cas systems, Science, vol.339, pp.819-823, 2013. ,
RNA-guided human genome engineering via Cas9, Science, vol.339, pp.823-826 ,
EPO revokes Broad's CRISPR patent, Nat. Biotechnol, vol.36, p.209, 2018. ,
Disruption and development: the evolving CRISPR patent and technology 486 landscape, Pharm. Pat. Anal, 2018. ,
The emerging patent landscape of 488 CRISPR-Cas gene editing technology, Nat. Biotechnol, vol.34, pp.1025-1031, 2016. ,
CRISPR-Cas9: a promising tool for gene editing on 490 induced pluripotent stem cells, Korean J. Intern. Med, vol.32, pp.42-61, 2017. ,
Chimeric antigen receptor T-Cell therapy for the 492 community oncologist, Oncologist, vol.21, pp.608-617, 2016. ,
The potential of the combination of CRISPR/Cas9 and pluripotent stem 494 cells to provide human organs from chimaeric pigs, Int. J. Mol. Sci, vol.16, p.495, 2015. ,
Advancing biotechnology with CRISPR/Cas9: recent 497 applications and patent landscape, J. Ind. Microbiol. Biotechnol, vol.45, p.498, 2018. ,
Editing EU legislation to fit plant genome 500 editing: The use of genome editing technologies in plant breeding requires a 501 novel regulatory approach for new plant varieties that involves farmers, EMBO, vol.502, pp.1365-1369, 2016. ,
Advances in genome editing for improved animal breeding: A review ,
, Vet. World, vol.10, pp.1361-1366, 2017.
European Paradox or Delusion-Are European 506 Science and Economy Outdated?, Science and Public Policy, vol.45, pp.14-23, 2018. ,
Patents, and the Public Health, Yale J. Biol. Med, vol.90, pp.667-672, 2017. ,
Patent protection for CRISPR: an ELSI review, J. Law Biosci, vol.4, p.510, 2017. ,
512 Inventive steps: the CRISPR patent dispute and scientific progress: The recent 513 patent decisions about CRISPR tell us a lot about how advances in biology are 514 actually made-and how they are not, EMBO Rep, vol.18, pp.1047-1051, 2017. ,
Timidity and a hostility to competition have left Europe a 516 scientific wasteland. The Telegraph, 2017. ,
The commercialization of genome-editing technologies, Crit. Rev ,
, , pp.1-12, 2017.
Technology protectionism and the patent system: strategic 520 technologies in China, 2016. ,